Veeva Crossix helps 16 of the top 20 biopharmas more efficiently reach clinically relevant patients PLEASANTON, Calif., April 23, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 16 of the top 20 biopharmas are increasing media efficiency with Veeva Crossix Prime Segments, privacy-safe data helping life sciences brands reach highly-qualified health audiences. Since launching in April 2023, Veeva Crossix Prime Segments have helped top biopharmas reach consumers that are 10 times more qual ...

Veeva AI Partner Program - Veeva Systems宣布推出Veeva AI Partner Program，为合作伙伴提供先进技术和支持，以便将生成式人工智能（GenAI）解决方案与Veeva Vault应用程序无缝集成[1] - Veeva AI Partner Program包括Vault Direct Data API培训和支持，以建立对Veeva Vault平台独特、高速API的专业知识。这种新型API使Vault数据可在比传统API快100倍的速度访问，并且在大型数据集上具有事务性和一致性[2] - Veeva AI Partner Program是Veeva专注于为生命科学行业提供人工智能的战略的一部分。Vault Direct Data API和AI合作伙伴计划使客户和合作伙伴更容易构建与Vault应用程序无缝集成的人工智能应用程序[4]

Veeva Systems财务表现 - Veeva Systems在2024财年的营收增长为9.7%，超出分析师预期的7.3%[2] - Veeva的总地址able市场（TAM）为200亿美元，仅有12%的渗透率，未来几年TAM可能会扩大[16] - 根据折现现金流（DCF）方法，Veeva的内在价值可能达到每股286美元，主要受益于过去6年FCF边际的增长[25][26][31][33] Veeva的商业模式和发展策略 - Veeva的商业模式展现出了弹性，即使在与美联储政策和客户对未来的悲观看法相关的不确定性情况下也能保持稳健[3] - 研发解决方案是未来增长的关键因素，结合Veeva Vault CRM迁移[5] - Veeva正在积极推进向Veeva Vault CRM的迁移计划，已有三家前20家制药公司完成迁移[9] Veeva与IQVIA的竞争和诉讼 - Veeva与IQVIA之间的诉讼可能存在风险，但预计无论结果如何，都不会对Veeva的增长前景产生重大影响[34] - Veeva采取更开放的方式处理与IQVIA的诉讼问题，提供给IQVIA获取Veeva产品的可能性[35] - Veeva的财务指标远远优于IQVIA，包括过去5年的FCF利润率和收入增长，Veeva的FCF利润率平均超过30%，年收入增长率在10%至30%之间[37]

Keynote speakers include leaders from Bayer, Genentech, Novo Nordisk, and Takeda sharing strategies for effective commercialization and engagement PLEASANTON, Calif., April 17, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from Bayer, Genentech, Novo Nordisk, Takeda, and others will be among the keynote speakers at the 2024 Veeva Commercial Summit, May 7-8 in Boston. Commercial and medical affairs professionals will share how they are innovating across content, data and analyt ...

产品介绍 - Veeva Systems推出Veeva Vault CRM Campaign Manager，简化并加速向医疗专业人士进行非个人推广[1] - Vault CRM Campaign Manager与Veeva Vault CRM同处一个Vault中，并共享相同的客户数据，为真正的客户中心性提供了无缝同步[1] 功能特点 - 用户可以定义一组活动，如电子邮件或短信，并将共享资产附加到活动中，所有活动都与活动相关联以确保合规性和分析[2] - 用户可以手动或动态创建客户段和目标列表，目标列表可以与多个活动关联，并可发布供现场协作使用[2] - 大规模电子邮件功能与现场团队紧密集成，使现场团队能够立即查看和控制发送给关键联系人的电子邮件，以增加客户中心性[3] 创新亮点 - 简单的拖放工具可创建所有内容类型，包括落地页、消息模板、电子邮件模板和片段，客户可以根据需要进行自定义[6] - Vault CRM Campaign Manager的推出是将销售和营销团队汇聚在一起实现客户中心性的又一步[7]

A downtrend has been apparent in Veeva Systems (VEEV) lately with too much selling pressure. The stock has declined 11.7% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for ...

The latest trading session saw Veeva Systems (VEEV) ending at $211.19, denoting a +0.13% adjustment from its last day's close. This change lagged the S&P 500's 0.74% gain on the day. At the same time, the Dow lost 0.01%, and the tech-heavy Nasdaq gained 1.68%.The provider of cloud-based software services for the life sciences industry's shares have seen a decrease of 10.17% over the last month, not keeping up with the Computer and Technology sector's gain of 0.95% and the S&P 500's gain of 0.8%.The investme ...

经纪推荐与股票评级 - 投资者通常依赖华尔街分析师的推荐来决定是否买入、卖出或持有股票[1] - Veeva Systems目前的平均经纪推荐（ABR）为1.80，介于强烈买入和买入之间[2] - 经纪推荐往往存在强烈的正向偏见，因为他们对所覆盖股票的利益[5] Zacks Rank与盈利预期 - Zacks Rank是一种有效的股票评级工具，可以有效预测股票未来的价格表现[7] - 经纪推荐和Zacks Rank是两种完全不同的衡量标准，前者基于经纪推荐，后者基于盈利预期修订[8] - 经纪推荐不一定是最新的，而Zacks Rank则会及时反映公司业务趋势的变化[13] Veeva Systems的盈利预期 - Veeva的盈利预期修订表现良好，Zacks Consensus Estimate为当前年度增长了5.3%至6.14美元[14] - 分析师对公司盈利前景的乐观态度，以及盈利预期修订的一致性，可能是股票在短期内飙升的合理原因[15] - Veeva的Zacks Rank为1（强烈买入），这与盈利预期修订的变化有关[16]

Veeva Systems’ (VEEV) shares lost 6.1% on Apr 2, following the mutually agreed-to announcement of the company’s CFO Brent Bowman's departure.Bowman's departure, though unexpected, is not linked to any misconduct or financial disagreements. He will continue to work as an employee of VEEV for three months to aid in the transition. Tim Cabral, a former CFO of Veeva Systems, will step in as interim CFO until a permanent replacement is found. Additionally, the company announced other changes in its executive tea ...

Veeva Systems’ (VEEV) shares lost 6.1% on Apr 2, following the sudden announcement of the company’s CFO Brent Bowman's resignation.Bowman's departure, though unexpected, is not linked to any misconduct or financial disagreements. He will continue to work as an employee of VEEV for three months to aid in the transition. Tim Cabral, a former CFO of Veeva Systems, will step in as interim CFO until a permanent replacement is found. Additionally, the company announced other changes in its executive team, includi ...